You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 125 No. 1, January 1990 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE NINTH ANNUAL MEETING OF THE SURGICAL INFECTION SOCIETY, DENVER, COLO, APRIL 13 TO APRIL 14, 1989-PAR T II
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Decreased Tumor Necrosis Factor Production During the Initial Stages of Infection Correlates With Survival During Murine Gram-negative Sepsis

Jaime L. Mayoral, MD; CyrilJ. Schweich; David L. Dunn, MD, PhD

Arch Surg. 1990;125(1):24-28.


Abstract

• Secretion of tumor necrosis factor (TNF)/cachectin occurs during gram-negative bacterial sepsis in response to macro-phage stimulation by lipopolysaccharide (endotoxin) and may play an early pivotal role in the subsequent host response. We sought to determine whether administration of: (1) murine monoclonal antibody directed against endotoxin, (2) steroids, or (3) antimicrobial agents would abrogate TNF production and whether the protective capacity would correlate with TNF levels in an experimental model of murine gram-negative bacterial sepsis. Mice were pretreated with anti–lipopolysaccharide monoclonal antibody, gentamicin sulfate, hydrocortisone, or saline and were then challenged with a lethal dose of intraperitoneal Salmonella minnesota. Murine serum TNF levels were measured by the L929 fibroblast cytotoxicity assay. Both gentamicin and anti–lipopolysaccharide monoclonal antibody significantly enhanced survival, and TNF activity at 1.5 and 3 hours was significantly suppressed in animals receiving these agents compared with animals that received either steroids or saline. We conclude that agents such as gentamicin, which inhibits bacterial replication, or monoclonal antibodies, which may neutralize lipopolysaccharide, indeed enhance survival, and survival was correlated with a significant reduction in circulating TNF during the early stages of infection.

(Arch Surg. 1990;125:24-28)



Author Affiliations

From the Division of Surgical Infectious Diseases, Department of Surgery, University of Minnesota, Minneapolis.


Footnotes

Accepted for publication September 12, 1989.

Read before the Ninth Annual Meeting of the Surgical Infection Society, Denver, Colo, April 13, 1989.

Reprints not available.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Bovine Intestinal Alkaline Phosphatase Attenuates the Inflammatory Response in Secondary Peritonitis in Mice
van Veen et al.
Infect. Immun. 2005;73:4309-4314.
ABSTRACT | FULL TEXT  

Detrimental Effects of a Nitric Oxide Synthase Inhibitor (N-{omega}-Nitro-L-Arginine-Methyl-Ester) in a Murine Sepsis Model
Fukatsu et al.
Arch Surg 1995;130:410-414.
ABSTRACT  

Inhibition of Splenic Macrophage Tumor Necrosis Factor {alpha} Secretion In Vivo by Antilipopolysaccharide Monoclonal Antibodies
Battafarano et al.
Arch Surg 1994;129:179-186.
ABSTRACT  

Anti--Endotoxin Monoclonal Antibodies Protect by Enhancing Bacterial and Endotoxin Clearance
Burd et al.
Arch Surg 1993;128:145-151.
ABSTRACT  

Anti--Tumor Necrosis Factor Antibody Reduces Mortality in the Presence of Antibiotic-Induced Tumor Necrosis Factor Release
Sawyer et al.
Arch Surg 1993;128:73-78.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.